Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Finance
Payers
Regulatory
Special Reports
Podcasts
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Whitepapers
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Finance
Payers
Regulatory
Special Reports
Podcasts
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Health Tech
Pfizer taps Tempus' AI for cancer drug development
Tempus has inked partnerships with three global pharma companies, representing about $700 million in revenue over the next few years.
Heather Landi
Mar 2, 2023 7:23am
Federal appeals court hands pharma a win on 340B restrictions
Jan 31, 2023 12:50pm
24 states support feds in 340B drugmaker lawsuit
May 17, 2022 7:50am
J&J to cut off 340B discounts to pharmacies starting in May
Mar 22, 2022 3:10pm
Judge sides with AstraZeneca in 340B contract pharmacy lawsuit
Feb 17, 2022 1:09pm
Bristol Myers Squibb latest to roll out 340B restrictions
Jan 19, 2022 9:30am